Drugs / fecal microbiota transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03008941 | Jan 2017 → Jun 2018 | HIV infectious disease | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fecal microbiota transplantation | “Fecal microbiota transplantation (FMT) is safe, not related to severe adverse events, and attenuates HIV-associated dysbiosis.” PMID 33602945 ↗ Feb 2021 |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03008941 ↗ |
| Route | Oral | “repeated low-dose oral fecal microbiota transplantation or placebo during 8 weeks” NCT03008941 ↗ |